Sunhawk Vision Biotech (ROCO:7759) EBITDA Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7759 Sunhawk Vision Biotech Inc ROCO:7759
12 GF Score
Price NT$31.40
! 1 Warning Sign
View Full Analysis

What is Sunhawk Vision Biotech EBITDA Margin %?

Sunhawk Vision Biotech ROCO:7759 +0.96% 12 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates ROCO:7759 with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 940 Biotechnology companies, Sunhawk Vision Biotech ranks worse than 106382.87% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sunhawk Vision Biotech's EBITDA for the six months ended in Dec. 2025 was NT$-74.20 Mil. Sunhawk Vision Biotech's Revenue for the six months ended in Dec. 2025 was NT$0.00 Mil. Therefore, Sunhawk Vision Biotech's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.

Sunhawk Vision Biotech  (ROCO:7759) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Sunhawk Vision Biotech EBITDA Margin % Related Terms

Sunhawk Vision Biotech EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Sunhawk Vision Biotech's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunhawk Vision Biotech EBITDA Margin % Chart

Sunhawk Vision Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial -4,160.08 0.00 0.00 0.00 0.00

Sunhawk Vision Biotech Semi-Annual Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

ROCO:7759 vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Sunhawk Vision Biotech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sunhawk Vision Biotech EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunhawk Vision Biotech's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Sunhawk Vision Biotech's EBITDA Margin % falls into.


ROCO:7759
12GF Score
Sunhawk Vision Biotech Inc ROCO:7759
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunhawk Vision Biotech EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Sunhawk Vision Biotech's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-166.462/0
= %

Sunhawk Vision Biotech's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-74.203/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Sunhawk Vision Biotech (ROCO:7759) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sunhawk Vision Biotech and its competitors. According to the industry distribution chart, Sunhawk Vision Biotech ranks #999999 out of 940 companies in the Biotechnology industry.
Is Sunhawk Vision Biotech's EBITDA Margin % too high?
Sunhawk Vision Biotech's current EBITDA Margin % is 0.00%. Based on the distribution chart, Sunhawk Vision Biotech ranks #999999 out of 940 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Sunhawk Vision Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Sunhawk Vision Biotech's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sunhawk Vision Biotech ranks #999999 out of 940 companies for EBITDA Margin %. This places Sunhawk Vision Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sunhawk Vision Biotech and its competitors. Sunhawk Vision Biotech's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunhawk Vision Biotech stock overvalued right now?
Sunhawk Vision Biotech (ROCO:7759) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Sunhawk Vision Biotech's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sunhawk Vision Biotech (ROCO:7759), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunhawk Vision Biotech Business Description

Address No. 6 Siwei 3rd Road, 17th Floor, Room A1, Lingya District, Kaohsiung, TWN
Sunhawk Vision Biotech Inc is a biotechnology company. The company is focused on developing new solutions for eye health and vision care. The company specializes in research and development of cutting-edge technologies aimed at treating and preventing ocular diseases. Their product portfolio includes products and services for curing dry eyes, myopia, and corneal erosion.
12GF Score

Get the complete analysis for ROCO:7759

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.40
Price